The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First update on overall survival, progression-free survival, and health-related time-to-deterioration quality of life from the NETTER-1 study: 177Lu-Dotatate vs. high dose octreotide in progressive midgut neuroendocrine tumors.
 
Jonathan R. Strosberg
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Speakers' Bureau - Ipsen; Lexicon
Research Funding - Novartis; Pharmacyclics
Travel, Accommodations, Expenses - Advanced Accelerator Applications
 
Edward M. Wolin
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Lexicon; Novartis
 
Beth A. Chasen
No Relationships to Disclose
 
Matthew H. Kulke
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Ipsen
 
David L Bushnell
Research Funding - Advanced Accelerator Applications
 
Martyn E. Caplin
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; NOVARTIS
Speakers' Bureau - ADVANCED ACCELERATOR APPLICATIONS; Ipsen
Research Funding - Advanced Accelerator Applications; Ipsen
 
Richard P. Baum
Stock and Other Ownership Interests - ADVANCED ACCELERATOR APPLICATIONS
Honoraria - ADVANCED ACCELERATOR APPLICATIONS; Ipsen
Consulting or Advisory Role - Ipsen
Research Funding - ADVANCED ACCELERATOR APPLICATIONS
 
Timothy J. Hobday
Consulting or Advisory Role - Abbvie; Ipsen
Research Funding - Novartis (Inst)
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Ipsen; Novartis; Perthera; Xbiotech
Travel, Accommodations, Expenses - Halozyme
 
Maribel Lopera Sierra
Employment - Advanced Accelerator Applications
Leadership - Advanced Accelerator Applications
Stock and Other Ownership Interests - Advanced Accelerator Applications
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Advanced Accelerator Applications
Research Funding - Advanced Accelerator Applications
Travel, Accommodations, Expenses - Advanced Accelerator Applications
Other Relationship - Advanced Accelerator Applications
 
Kjell E. Oberg
Consulting or Advisory Role - Ipsen; Novartis
Speakers' Bureau - Ipsen; Novartis Canada Pharmaceuticals Inc
 
Philippe B. Ruszniewski
No Relationships to Disclose
 
Eric Krenning
Stock and Other Ownership Interests - ADVANCED ACCELERATOR APPLICATIONS